Understanding the mechanisms that ensure higher agricultural productivity can help the nation develop crop strains that are resistant to biotic and abiotic stresses and/or utilize soil nutrition efficiently.

Learning the intricacies of hematopoiesis, the formation of blood cells during embryonic development and adulthood, and the biology of stem cells will help us decipher the cellular processes underlying certain cancers and blood disorders and develop therapeutic interventions.

TIGS is exploring pathways to reverse antibiotic resistance in select pathogenic bacteria. The research holds promise in combating antibiotic-resistant superbugs, which are becoming an increasing concern in global healthcare.

Research groups at TIGS are working on applying new tools and techniques in genetics for sustainable, safe, and ethical management of mosquito-borne diseases such as malaria, Zika, dengue and chikungunya.

TIGS is working on identifying antibody fragments with pathogen-blocking properties. Research at TIGS aims to engineer such fragments and study their stability, affinity, avidity and efficacy and to use them to control disease transmission.

A dedicated group of researchers at TIGS studies, evaluates and addresses the ethical, social and moral concerns of new genetic technologies. Public debates and discussion forums with both regulators and the community foster a participatory approach to disseminating new technologies.